Clinical Trial Update: Study to Learn How the Drug Aflibercept Works in in Japanese Patients With Increased Eye Pressure That is Caused by New Blood Vessels Growing in the Eye (Neovascular Glaucoma or NVG). Safety of the Drug and Patients' Tolerability of the Drug Injection is Also Studied [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating how aflibercept works in Japanese patients with neovascular glaucoma, focusing on safety and tolerability of intravitreal injections;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Neovascular Glaucoma

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Bayer | Conditions: Glaucoma, Neovascular | Phase 3 | Status: COMPLETED | Results posted: 2020-02-18